•  After the publication of its May 2022 Enforcement Discretion Guidance (discussed here), FDA issued letters of enforcement discretion to various companies for marketing specific infant formula products in the

Continue Reading New FDA Guidance Allows Companies to Continue Marketing Infant Formula Under an Enforcement Discretion Letter Beyond November 14, 2022

  • On May 27, 2020, the U.S. Food and Drug Administration (FDA) released a guidance document entitled “Reporting a Temporary Closure or Significantly Reduced Production by a Human Food Establishment and

Continue Reading FDA Provides Guidance Document on Reporting Human Food Establishments’ Temporary Closures or Significantly Reduced Production